GGrantIndex
← Leaderboards

Michael R King

University Of Pennsylvania

$8,012,934
Attributed
$8,997,452
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,997,452 · 6

By mechanism

R01$5,604,407 · 3
U54$1,956,654 · 1
P01$1,375,615 · 1
F32$60,776 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsResponseSiteIn VivoLigandsPhenotypeIn VitroMolecularShear StressReceptorPrimary NeoplasmNeoplasm MetastasisMalignant NeoplasmsCancer CellFlow CytometryMechanicsCell LineBlood FlowSurfaceEnvironmentBloodBehaviorPharmaceutical PreparationsBinding (Molecular Function)

Grant awards (29)

Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow$380,046
R01 · FY2025 · CA · contact PI
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow$364,723
R01 · FY2024 · CA · contact PI
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow$350,423
R01 · FY2023 · CA · contact PI
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow$363,707
R01 · FY2022 · CA · contact PI
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes$409,817
R01 · FY2021 · CA · contact PI
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow$297,905
R01 · FY2021 · CA · contact PI
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes$409,743
R01 · FY2020 · CA · contact PI
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes$328,611
R01 · FY2019 · CA · contact PI
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes$38,192
R01 · FY2019 · CA · contact PI
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes$338,776
R01 · FY2018 · CA · contact PI
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes$337,277
R01 · FY2017 · CA · contact PI
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes$16,150
R01 · FY2017 · CA · contact PI
Model of Platelet Adhesion and Thrombus Formation$395,048
R01 · FY2014 · HL · contact PI
Hydrodynamic Interactions and Cell Deformation in Neutrophil Adhesion$212,053
P01 · FY2014 · HL · contact PI
Model of Platelet Adhesion and Thrombus Formation$375,127
R01 · FY2013 · HL · contact PI
Adhesion of Metastatic Tumor Cells in the Bloodstream$317,631
U54 · FY2013 · CA · contact PI
Hydrodynamic Interactions and Cell Deformation in Neutrophil Adhesion$274,759
P01 · FY2013 · HL · contact PI
Model of Platelet Adhesion and Thrombus Formation$393,081
R01 · FY2012 · HL · contact PI
Adhesion of Metastatic Tumor Cells in the Bloodstream$365,089
U54 · FY2012 · CA · contact PI
Hydrodynamic Interactions and Cell Deformation in Neutrophil Adhesion$301,907
P01 · FY2012 · HL · contact PI
Adhesion of Metastatic Tumor Cells in the Bloodstream$480,423
U54 · FY2011 · CA · contact PI
Model of Platelet Adhesion and Thrombus Formation$396,130
R01 · FY2011 · HL · contact PI
Hydrodynamic Interactions and Cell Deformation in Neutrophil Adhesion$261,178
P01 · FY2011 · HL · contact PI
Model of Platelet Adhesion and Thrombus Formation$409,651
R01 · FY2010 · HL · contact PI
Adhesion of Metastatic Tumor Cells in the Bloodstream$401,884
U54 · FY2010 · CA · contact PI
Hydrodynamic Interactions and Cell Deformation in Neutrophil Adhesion$325,718
P01 · FY2010 · HL · contact PI
Adhesion of Metastatic Tumor Cells in the Bloodstream$391,627
U54 · FY2009 · CA · contact PI
HYDRODYNAMIC INTERACTIONS BETWEEN ADHERING NEUTROPHILS$29,860
F32 · FY2001 · HL
HYDRODYNAMIC INTERACTIONS BETWEEN ADHERING NEUTROPHILS$30,916
F32 · FY2000 · HL